RECORLEV® - PANTHERx Rare

RECORLEV® (levoketoconazole)
www.recorlev.com

RECORLEV (levoketoconazole) is a cortisol synthesis inhibitor indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.

Resources

Cushing’s Support & Research Foundation EXPLORE

National Adrenal Disease Foundation EXPLORE

Pituitary Network Association EXPLORE

National Organization for Rare Disorders (NORD)National Organization for Rare Disorders (NORD) EXPLORE

PANTHERx Rare Contact

844-444-7258

Manufacturer Contact

Xeris Pharmaceuticals
https://www.xerispharma.com/
844.445.5704

7x Winner of the MMIT Patient Choice Award!

Give us a call 855.726.8479 | 412.246.9858

Endogenous Cushing’s Syndrome (CS)

Resources

PANTHERx Rare Contact

Manufacturer Contact